Access and Support
How to order and access ONUREG®
DOWNLOADAuthorized distributors
The following distributors are authorized to sell ONUREG® and are able to service qualified accounts.
Authorized Distributor Network
Community Practices
Phone: 1-877-453-3972
https://specialtyonline.cardinalhealth.comPhone: 1-800-482-6700Fax: 1-800-289-9285
https://mscs.mckesson.comPhone: 1-800-633-7555Fax: 1-800-248-8205
https://oncologysupply.comSpecialty Pharmacies and Institutions/Hospital Outpatient Facilities
Phone: 1-800-746-6273Fax: 1-800-547-9413
https://www.asdhealthcare.comPhone: 1-866-677-4844Fax: 1-614-553-6301
https://orderexpress.cardinalhealth.comPhone: 1-877-625-2566Fax: 1-888-752-7626
https://connect.mckesson.comPuerto Rico Hospitals and Oncology Clinics
Phone: 1-787-625-4100Fax: 1-787-625-4398
https://www.cardinalhealth.prPhone: 1-787-999-1616Fax: 1-787-999-1618
https://www.facilfarmaciacci.comAML ICD-10-CM diagnosis codesa
ICD-10-CM code
Descriptor
C92.00
Acute myeloblastic leukemia, not having achieved remission
C92.01
Acute myeloblastic leukemia, in remission
C92.50
Acute myelomonocytic leukemia, not having achieved remission
C92.51
Acute myelomonocytic leukemia, in remission
C92.60
Acute myeloid leukemia with 11q23-abnormality, not having achieved remission
C92.61
Acute myeloid leukemia with 11q23-abnormality, in remission
C92.A0
Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
C92.A1
Acute myeloid leukemia with multilineage dysplasia, in remission
C92.Z0
Other myeloid leukemia, not having achieved remission
C92.Z1
Other myeloid leukemia, in remission
C92.90
Myeloid leukemia, unspecified, not having achieved remission
C92.91
Myeloid leukemia, unspecified, in remission
C93.00
Acute monoblastic/monocytic leukemia, not having achieved remission
C93.01
Acute monoblastic/monocytic leukemia, in remission
C94.00
Acute erythroid leukemia, not having achieved remission
C94.01
Acute erythroid leukemia, in remission
C94.20
Acute megakaryoblastic leukemia, not having achieved remission
C94.21
Acute megakaryoblastic leukemia, in remission
ICD-10-CM, International Classification of Diseases, Tenth Revision, Clinical Modification.
aThese codes are not all-inclusive.
The information contained herein is not intended to provide specific coding and reimbursement advice for any specific patient or situation. You should check with your coding specialist to ensure appropriate submissions.
Product information
National Drug Codes (NDC) and packaging information
HCPCS code
Descriptor
10-digit NDC
11-digit NDCa
200 mg
Bottles of 14 with 2 desiccant canisters
59572-730-14
59572-0730-14
300 mg
Bottles of 14 with 2 desiccant canisters
59572-740-14
59572-0740-14
200 mg
One blister card containing 7 tablets
59572-730-07
59572-0730-07
300 mg
One blister card containing 7 tablets
59572-740-07
59572-0740-07
10-digit NDC
11-digit NDCa
59572-730-14
59572-0730-14
HCPCS code
Descriptor
300 mg
Bottles of 14 with 2 desiccant canisters
10-digit NDC
11-digit NDCa
59572-740-14
59572-0740-14
HCPCS code
Descriptor
200 mg
One blister card containing 7 tablets
10-digit NDC
11-digit NDCa
59572-730-07
59572-0730-07
HCPCS code
Descriptor
300 mg
One blister card containing 7 tablets
10-digit NDC
11-digit NDCa
59572-740-07
59572-0740-07
aThe red zero converts the 10-digit NDC to the 11-digit NDC. Payer requirements regarding the use of NDCs may vary. Electronic data exchange generally requires use of the 11-digit NDC.
Access and reimbursement resources to support your patients on ONUREG®
Three Simple Ways to Get Support
Contact your Access & Reimbursement Manager for general assistance and to schedule an office visit
Call Bristol Myers Squibb Access Support® at 1-800-861-0048, 8 am to 8 pm ET, Monday-Friday, to speak with a regionally assigned specialist
Visit www.BMSAccessSupport.com for information and resources, including the enrollment form, to help you and your patients with access to Bristol Myers Squibb products
Bristol Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement support services.